Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Jun. 30, 2015 | Jul. 31, 2015 | |
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2015 | |
Document Fiscal Year Focus | 2,015 | |
Document Fiscal Period Focus | Q3 | |
Trading Symbol | NUAN | |
Entity Registrant Name | Nuance Communications, Inc. | |
Entity Central Index Key | 1,002,517 | |
Current Fiscal Year End Date | --09-30 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 309,792,980 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Revenues: | ||||
Product and licensing | $ 162,806 | $ 168,224 | $ 506,945 | $ 521,480 |
Professional services and hosting | 234,253 | 231,698 | 684,927 | 677,359 |
Maintenance and support | 80,880 | 75,582 | 235,145 | 222,298 |
Total revenues | 477,939 | 475,504 | 1,427,017 | 1,421,137 |
Cost of revenues: | ||||
Product and licensing | 21,276 | 23,934 | 68,498 | 74,598 |
Professional services and hosting | 153,924 | 163,587 | 462,188 | 475,604 |
Maintenance and support | 13,715 | 13,566 | 41,151 | 38,533 |
Amortization of intangible assets | 15,776 | 15,006 | 46,538 | 45,542 |
Total cost of revenues | 204,691 | 216,093 | 618,375 | 634,277 |
Gross profit | 273,248 | 259,411 | 808,642 | 786,860 |
Operating expenses: | ||||
Research and development | 79,050 | 87,137 | 236,393 | 252,188 |
Sales and marketing | 99,285 | 99,783 | 303,789 | 316,969 |
General and administrative | 40,977 | 43,732 | 137,278 | 131,890 |
Amortization of intangible assets | 26,371 | 27,287 | 78,526 | 81,330 |
Acquisition-related costs, net | 2,423 | 9,110 | 13,702 | 18,710 |
Restructuring and other charges, net | 10,808 | 8,622 | 12,703 | 17,178 |
Total operating expenses | 258,914 | 275,671 | 782,391 | 818,265 |
Income (loss) from operations | 14,334 | (16,260) | 26,251 | (31,405) |
Other income (expense): | ||||
Interest income | 670 | 535 | 1,859 | 1,728 |
Interest expense | (29,486) | (31,926) | (89,417) | (99,872) |
Other (expense) income, net | (18,375) | 363 | (19,270) | (3,007) |
Loss before income taxes | (32,857) | (47,288) | (80,577) | (132,556) |
Provision for income taxes | 6,533 | 6,959 | 23,406 | 16,331 |
Net loss | $ (39,390) | $ (54,247) | $ (103,983) | $ (148,887) |
Net loss per share: | ||||
Basic (in dollars per share) | $ (0.13) | $ (0.17) | $ (0.33) | $ (0.47) |
Diluted (in dollars per share) | $ (0.13) | $ (0.17) | $ (0.33) | $ (0.47) |
Weighted average common shares outstanding: | ||||
Basic (in shares) | 312,680 | 317,610 | 319,415 | 316,334 |
Diluted (in shares) | 312,680 | 317,610 | 319,415 | 316,334 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Net loss | $ (39,390) | $ (54,247) | $ (103,983) | $ (148,887) |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustment | 17,007 | 9,693 | (60,733) | 15,170 |
Pension Adjustments | 245 | 520 | (489) | 520 |
Unrealized (loss) gain on marketable securities | (22) | 0 | 7 | 0 |
Total other comprehensive income (loss), net | 17,230 | 10,213 | (61,215) | 15,690 |
Comprehensive loss | $ (22,160) | $ (44,034) | $ (165,198) | $ (133,197) |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2015 | Sep. 30, 2014 |
Current assets: | ||
Cash and cash equivalents | $ 397,116 | $ 547,230 |
Marketable securities | 54,697 | 40,974 |
Accounts receivable, less allowances for doubtful accounts of $8,067 and $11,491 | 365,661 | 428,266 |
Prepaid expenses and other current assets | 87,424 | 92,040 |
Deferred tax assets | 61,323 | 55,990 |
Total current assets | 966,221 | 1,164,500 |
Marketable securities | 36,876 | 0 |
Land, building and equipment, net | 191,814 | 191,411 |
Goodwill | 3,392,844 | 3,410,893 |
Intangible assets, net | 847,205 | 915,483 |
Other assets | 154,061 | 137,997 |
Total assets | 5,589,021 | 5,820,284 |
Current liabilities: | ||
Current portion of long-term debt | 4,834 | 4,834 |
Contingent And Deferred Acquisition Payments | 21,929 | 35,911 |
Accounts payable | 42,771 | 61,760 |
Accrued expenses and other current liabilities | 203,547 | 241,279 |
Deferred revenue | 327,736 | 298,225 |
Total current liabilities | 600,817 | 642,009 |
Long-term debt | 2,113,741 | 2,127,392 |
Deferred revenue, net of current portion | 319,895 | 249,879 |
Deferred tax liabilities | 170,087 | 156,235 |
Other liabilities | 57,221 | 62,777 |
Total liabilities | $ 3,261,761 | $ 3,238,292 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value; 560,000 shares authorized; 314,691 and 324,621 shares issued and 310,940 and 320,870 shares outstanding, respectively | $ 315 | $ 325 |
Additional paid-in capital | 3,144,108 | 3,153,033 |
Treasury stock, at cost (3,751 shares) | (16,788) | (16,788) |
Accumulated other comprehensive loss | (85,230) | (24,015) |
Accumulated deficit | (715,145) | (530,563) |
Total stockholders’ equity | 2,327,260 | 2,581,992 |
Total liabilities and stockholders’ equity | $ 5,589,021 | $ 5,820,284 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands | Jun. 30, 2015 | Sep. 30, 2014 |
Accounts receivable, allowances for doubtful accounts | $ 8,067 | $ 11,491 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 560,000 | 560,000 |
Common stock, shares issued | 314,691 | 324,621 |
Common stock, shares outstanding | 310,940 | 320,870 |
Treasury stock, shares | 3,751 | 3,751 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Cash flows from operating activities: | ||
Net loss | $ (103,983) | $ (148,887) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 171,892 | 165,280 |
Stock-based compensation | 119,972 | 147,541 |
Non-cash interest expense | 22,078 | 28,187 |
Gains (Losses) on Extinguishment of Debt | (17,714) | 0 |
Deferred tax provision | 7,529 | 2,351 |
Other | 5,641 | (4,294) |
Changes in operating assets and liabilities, net of effects from acquisitions: | ||
Accounts receivable | 50,990 | (4,706) |
Prepaid expenses and other assets | (14,709) | (9,453) |
Accounts payable | (14,647) | (25,003) |
Accrued expenses and other liabilities | (43,167) | 3,634 |
Deferred revenue | 116,660 | 107,563 |
Net cash provided by operating activities | 335,970 | 262,213 |
Cash flows from investing activities: | ||
Capital expenditures | (48,159) | (41,359) |
Payments for business and technology acquisitions, net of cash acquired | (82,034) | (136,183) |
Payments to Acquire Investments | 114,765 | 19,613 |
Proceeds from sales and maturities of marketable securities and other investments | 49,481 | 32,851 |
Net cash used in investing activities | (195,477) | (164,304) |
Cash flows from financing activities: | ||
Payments of debt | (259,843) | (3,855) |
Proceeds from issuance of convertible debt, net of issuance cost | 256,212 | 0 |
Payments for repurchase of common stock | (238,203) | (26,483) |
Payments for settlement of share-based derivatives | (340) | (5,286) |
Payments of other long-term liabilities | (2,383) | (2,216) |
Proceeds from issuance of common stock from employee stock plans | 12,335 | 13,525 |
Cash used to net share settle employee equity awards | (53,273) | (35,318) |
Net cash used in financing activities | (285,495) | (59,633) |
Effects of exchange rate changes on cash and cash equivalents | (5,112) | 542 |
Net (decrease) increase in cash and cash equivalents | (150,114) | 38,818 |
Cash and cash equivalents at beginning of period | 547,230 | 808,118 |
Cash and cash equivalents at end of period | $ 397,116 | $ 846,936 |
Organization and Presentation
Organization and Presentation | 9 Months Ended |
Jun. 30, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Presentation | Organization and Presentation The consolidated financial statements include the accounts of Nuance Communications, Inc. (“Nuance”, “we”, or “the Company”) and our wholly-owned subsidiaries. We prepared these unaudited interim consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The condensed consolidated financial statements reflect all adjustments that, in our opinion, are necessary to present fairly our financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although we believe the disclosures in these financial statements are adequate to make the information presented not misleading, certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in our latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. Accordingly, these financial statements should be read in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014 . The results of operations for the nine months ended June 30, 2015 and June 30, 2014 , respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. We have evaluated subsequent events through the date of the issuance of these condensed consolidated financial statements. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Jun. 30, 2015 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Effective October 1, 2014, we implemented Accounting Standards Update No. 2013-11, " Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists " , which did not have a significant impact on our consolidated financial statements. We have made no material changes to the significant accounting policies disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014. Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board and are adopted by us as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on our condensed consolidated financial position, results of operations and cash flows or do not apply to our operations. In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs" ("ASU 2015-03"). The amendments in the ASU 2015-03 require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for us in the first quarter of fiscal year 2017, with early adoption permitted. ASU 2015-03 should be applied on a retrospective basis to each individual period presented. Upon implementation, the change in reporting debt issuance costs will require us to reclassify our deferred financing costs from an asset to a reduction of the reported debt balance. ASU 2015-03 will reduce our assets and liabilities but will have no impact on our shareholders' equity, results of operations or cash flows. In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Amendments to the Consolidation Analysis” ("ASU 2015-02"). The amendments in ASU 2015-02 provide guidance on evaluating whether a company should consolidate certain legal entities. In accordance with the guidance, all legal entities are subject to reevaluation under the revised consolidation model. ASU 2015-02 is effective for us in the first quarter of fiscal year 2017 with early adoption permitted. We do not believe that ASU 2015-02 will have a material impact on our consolidated financial statements. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, "Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" ("ASU 2014-15"), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in the first quarter of fiscal year 2017, with early adoption permitted. We do not believe that ASU 2014-15 will have a material impact on our consolidated financial statements. In June 2014, the FASB issued Accounting Standards Update No. 2014-12, " Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period" ("ASU 2014-12"). ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in ASC 718, "Compensation - Stock Compensation," as it relates to such awards. ASU 2014-12 is effective for us in our first quarter of fiscal year 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. We are currently evaluating the impact of our pending adoption on ASU 2014-12 on our consolidated financial statements. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers: Topic 606" ("ASU 2014-09"), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for us in our first quarter of fiscal year 2018 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU 2014-09. We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" ("ASU 2014-08"), to change the criteria for determining which disposals can be presented as discontinued operations and enhanced the related disclosure requirements. ASU 2014-08 is effective for us on a prospective basis in our first quarter of fiscal year 2016 with early adoption permitted for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. We are currently evaluating the impact of our pending adoption of ASU 2014-08 on our consolidated financial statements. |
Business Acquisitions
Business Acquisitions | 9 Months Ended |
Jun. 30, 2015 | |
Business Combinations [Abstract] | |
Business Acquisitions | Business Acquisitions During fiscal year 2015, we acquired several immaterial businesses in our Mobile and Consumer and Healthcare segments for total initial cash consideration of $47.9 million together with future contingent payments. The future contingent payments may require us to make payments up to $19.9 million as additional consideration contingent upon the achievement of specified objectives, which at closing had an estimated fair value of $16.1 million . In allocating the total purchase consideration for these acquisitions based on preliminary estimated fair values, we recorded $22.6 million of goodwill and $35.8 million of identifiable intangibles assets. Intangible assets acquired included customer relationships and core and completed technology with weighted average useful lives of 6.6 years. The most significant of these acquisitions are treated as asset purchases, and the goodwill resulting from these acquisitions is expected to be deductible for tax purposes. We have not furnished pro forma financial information related to our current year acquisitions because such information is not material, individually or in the aggregate, to our financial results. During fiscal year 2014, we acquired several immaterial businesses in our Imaging, Healthcare and Enterprise segments for total initial cash consideration of $258.3 million together with future contingent payments. In allocating the total purchase consideration for these acquisitions based on preliminary estimated fair values, we recorded $139.4 million of goodwill and $134.5 million of identifiable intangibles assets. Intangible assets acquired included customer relationships and core and completed technology with weighted average useful lives of 10.2 years. The most significant of these acquisitions are treated as stock purchases, and the goodwill resulting from these acquisitions is not expected to be deductible for tax purposes. The fair value estimates for the assets acquired and liabilities assumed for acquisitions completed during fiscal years 2015 and 2014 were based upon preliminary calculations and valuations, and our estimates and assumptions for each of these acquisitions are subject to change as we obtain additional information during the respective measurement periods (up to one year from the respective acquisition dates). The primary areas of preliminary estimates that were not yet finalized related to certain assets and liabilities acquired. There were no significant changes to the fair value estimates during the current year. Acquisition-Related Costs, net Acquisition-related costs include costs related to business and other acquisitions, including potential acquisitions. These costs consist of (i) transition and integration costs, including retention payments, transitional employee costs and earn-out payments treated as compensation expense, as well as the costs of integration-related activities including services provided by third-parties; (ii) professional service fees, including third party costs related to the acquisitions, and legal and other professional service fees associated with disputes and regulatory matters related to acquired entities; and (iii) adjustments to acquisition-related items that are required to be marked to fair value each reporting period, such as contingent consideration, and other items related to acquisitions for which the measurement period has ended. The components of acquisition-related costs, net are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Transition and integration costs $ 2,923 $ 5,612 $ 9,160 $ 14,041 Professional service fees 1,431 3,363 7,117 9,101 Acquisition-related adjustments (1,931 ) 135 (2,575 ) (4,432 ) Total $ 2,423 $ 9,110 $ 13,702 $ 18,710 Included in acquisition-related adjustments for the nine months ended June 30, 2014 , is income of $7.7 million related to the elimination of contingent liabilities established in the original allocation of purchase price for acquisitions closed in fiscal year 2008, following the expiration of the applicable statute of limitations. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 9 Months Ended |
Jun. 30, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill and intangible assets for the nine months ended June 30, 2015 , are as follows (dollars in thousands): Goodwill Intangible Assets Balance at September 30, 2014 $ 3,410,893 $ 915,483 Acquisitions 22,552 65,622 Dispositions — (2,806 ) Purchase accounting adjustments (1,237 ) (554 ) Amortization — (125,064 ) Effect of foreign currency translation (39,364 ) (5,476 ) Balance at June 30, 2015 $ 3,392,844 $ 847,205 In October 2014, we realigned certain of our product offerings among reporting units. We have reallocated goodwill among the affected reporting units, based on their relative fair value. We reallocated $29.9 million of goodwill from our Dragon Consumer reporting unit into our Mobile reporting unit, and reallocated $10.5 million of goodwill from our Mobile reporting unit to our Enterprise reporting unit. As a result of this change, we determined that we had a triggering event requiring us to perform an impairment test on our Dragon Consumer ("DNS"), Mobile, and Enterprise reporting units. We completed our impairment test during the first quarter of fiscal year 2015, and the fair value of the reorganized reporting units substantially exceeded their carrying values. |
Financial Instruments and Hedgi
Financial Instruments and Hedging Activities | 9 Months Ended |
Jun. 30, 2015 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments and Hedging Activities | Financial Instruments and Hedging Activities Derivatives Not Designated as Hedges Forward Currency Contracts We operate our business in countries throughout the world and transact business in various foreign currencies. Our foreign currency exposures typically arise from transactions denominated in currencies other than the functional currency of our operations. We have a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effect of certain foreign currency exposures. Our program is designed so that increases or decreases in our foreign currency exposures are offset by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with our foreign currency transactions. Generally, we enter into such contracts for less than 90 days and have no cash requirements until maturity. At June 30, 2015 and September 30, 2014 , we had outstanding contracts with a total notional value of $161.9 million and $283.1 million , respectively. We have not designated these forward contracts as hedging instruments pursuant to the authoritative guidance for derivatives and hedging, and accordingly, we record the fair value of these contracts at the end of each reporting period in our consolidated balance sheet, with the unrealized gains and losses recognized immediately in earnings as other (expense) income, net in our consolidated statements of operations. The cash flows related to the settlement of these contracts are included in cash flows from investing activities within our condensed consolidated statement of cash flows. Security Price Guarantees From time to time we enter into agreements that allow us to issue shares of our common stock as part or all of the consideration related to business acquisitions, partnering and technology acquisition activities. Some of these shares are issued subject to security price guarantees, which are accounted for as derivatives. We have determined that these instruments would not be considered equity instruments if they were freestanding. Certain of the security price guarantees require payment from either us to a third party, or from a third party to us, based upon the difference between the price of our common stock on the issue date and an average price of our common stock approximately six months following the issue date. We have also issued minimum price guarantees that may require payments from us to a third party based on the average share price of our common stock approximately six months following the issue date if our stock price falls below the minimum price guarantee. Changes in the fair value of these security price guarantees are reported in other (expense) income, net in our consolidated statements of operations. We have no outstanding shares subject to security price guarantees at June 30, 2015 . The following table provides a quantitative summary of the fair value of our derivative instruments as of June 30, 2015 and September 30, 2014 (dollars in thousands): Derivatives Not Designated as Hedges: Balance Sheet Classification Fair Value June 30, 2015 September 30, 2014 Foreign currency contracts Accrued expenses and other current liabilities $ (550 ) $ (272 ) Security Price Guarantees Accrued expenses and other current liabilities — (135 ) Net fair value of non-hedge derivative instruments $ (550 ) $ (407 ) The following tables summarize the activity of derivative instruments for the three and nine months ended June 30, 2015 and 2014 (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, Derivatives Not Designated as Hedges Location of Gain (Loss) Recognized in Income 2015 2014 2015 2014 Foreign currency contracts Other income (expense), net $ 3,078 $ 2,965 $ (16,019 ) $ 9,338 Security price guarantees Other income (expense), net $ 334 $ 650 $ (204 ) $ (3,572 ) Other Financial Instruments Financial instruments including cash equivalents, accounts receivable and accounts payable are carried in the consolidated financial statements at amounts that approximate their fair value based on the short maturities of those instruments. Marketable securities and derivative instruments are carried at fair value. The estimated fair value of our long-term debt approximated $2,243.4 million (face value $2,221.4 million ) and $2,179.2 million (face value $2,217.4 million ) at June 30, 2015 and September 30, 2014 , respectively. These fair value amounts represent the value at which our lenders could trade our debt within the financial markets and do not represent the settlement value of these long-term debt liabilities to us at each reporting date. The fair value of the long-term debt issues will continue to vary each period based on fluctuations in market interest rates, as well as changes to our credit ratings. The Senior Notes, the term loan portion of our Credit Facility, and the Convertible Debentures are traded and the fair values of each borrowing was estimated using the averages of the bid and ask trading quotes at each respective reporting date. We had no outstanding balance on the revolving credit line portion of our Credit Facility at June 30, 2015 or September 30, 2014 . |
Fair Value Measures
Fair Value Measures | 9 Months Ended |
Jun. 30, 2015 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measures | Fair Value Measures Fair value is defined as the price that would be received for an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Valuation techniques must maximize the use of observable inputs and minimize the use of unobservable inputs. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The following summarizes the three levels of inputs required to measure fair value, of which the first two are considered observable and the third is considered unobservable: • Level 1. Quoted prices for identical assets or liabilities in active markets which we can access. • Level 2. Observable inputs other than those described as Level 1. • Level 3. Unobservable inputs based on the best information available, including management’s estimates and assumptions. Assets and liabilities measured at fair value on a recurring basis at June 30, 2015 and September 30, 2014 consisted of (dollars in thousands): June 30, 2015 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 245,742 $ — $ — $ 245,742 US government agency securities (a) 1,000 — — 1,000 Time deposits (b) — 57,378 — 57,378 Commercial paper, $3,784 at cost (b) — 3,788 — 3,788 Corporate notes and bonds, $46,139 at cost (b) — 46,142 — 46,142 Total assets at fair value $ 246,742 $ 107,308 $ — $ 354,050 Liabilities: Foreign currency exchange contracts (b) $ — $ (550 ) $ — $ (550 ) Contingent acquisition payments (d) — — (20,187 ) (20,187 ) Total liabilities at fair value $ — $ (550 ) $ (20,187 ) $ (20,737 ) September 30, 2014 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 407,749 $ — $ — $ 407,749 US government agency securities (a) 1,000 — — 1,000 Time deposits (b) — 46,604 — 46,604 Total assets at fair value $ 408,749 $ 46,604 $ — $ 455,353 Liabilities: Foreign currency exchange contracts (b) $ — $ (272 ) $ — $ (272 ) Security price guarantees (c) — (135 ) — (135 ) Contingent acquisition payments (d) — — (6,864 ) (6,864 ) Total liabilities at fair value $ — $ (407 ) $ (6,864 ) $ (7,271 ) (a) Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. (b) The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. (c) The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. (d) The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. Time deposits are generally for terms of one year or less. The commercial paper and corporate notes and bonds mature within three years and have a weighted average maturity of 1.56 years. The changes in the fair value of contingent acquisition payment liabilities are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2015 Balance at beginning of period $ 3,931 $ 6,864 Earn-out liabilities established at time of acquisition 15,997 16,082 Payments upon settlement (174 ) (3,112 ) Adjustments to fair value included in acquisition-related costs, net 433 353 Balance at end of period $ 20,187 $ 20,187 Our financial liabilities valued based upon Level 3 inputs are composed of contingent consideration arrangements relating to our acquisitions. We are contractually obligated to pay contingent consideration to the selling shareholders upon the achievement of specified objectives, including the achievement of future bookings and sales targets related to the products of the acquired entities and therefore are recorded as contingent consideration liabilities at the time of the acquisitions. We update our assumptions each reporting period based on new developments and record such amounts at fair value based on the revised assumptions until the consideration is paid upon the achievement of the specified objectives or eliminated upon failure to achieve the specified objectives. Contingent acquisition payment liabilities are scheduled to be paid in periods through fiscal year 2016 . As of June 30, 2015 , we could be required to pay up to $36.0 million for contingent consideration arrangements if the specified objectives are achieved. We have determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are the estimated cash flows projected from future product sales and the risk adjusted discount rate for the fair value measurement. |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 9 Months Ended |
Jun. 30, 2015 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (dollars in thousands): June 30, 2015 September 30, 2014 Compensation $ 107,547 $ 146,730 Cost of revenue related liabilities 25,331 22,340 Accrued interest payable 23,435 15,092 Professional fees 9,307 10,852 Sales and marketing incentives 7,847 10,188 Sales and other taxes payable 6,024 9,367 Acquisition costs and liabilities 5,505 9,307 Facilities related liabilities 5,514 5,720 Liability for unsettled share repurchases 4,463 — Other 8,574 11,683 Total $ 203,547 $ 241,279 |
Deferred Revenue
Deferred Revenue | 9 Months Ended |
Jun. 30, 2015 | |
Deferred Revenue [Abstract] | |
Deferred Revenue | Deferred Revenue Deferred maintenance revenue consists of prepaid fees received for post-contract customer support for our products, including telephone support and the right to receive unspecified upgrades/updates on a when-and-if-available basis. Unearned revenue includes upfront fees for setup and implementation activities related to hosted offerings; certain software arrangements for which we do not have fair value of post-contract customer support, resulting in ratable revenue recognition for the entire arrangement on a straight-line basis; and fees in excess of estimated earnings on percentage-of-completion service contracts. Deferred revenue consisted of the following (dollars in thousands): June 30, 2015 September 30, 2014 Current liabilities: Deferred maintenance revenue $ 153,941 $ 140,737 Unearned revenue 173,795 157,488 Total current deferred revenue $ 327,736 $ 298,225 Long-term liabilities: Deferred maintenance revenue $ 61,505 $ 60,398 Unearned revenue 258,390 189,481 Total long-term deferred revenue $ 319,895 $ 249,879 |
Restructuring and Other Charges
Restructuring and Other Charges, net | 9 Months Ended |
Jun. 30, 2015 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Related Activities Disclosure [Text Block] | Restructuring and Other Charges, net Restructuring and other charges, net include restructuring expenses together with other charges that are unusual in nature and are the result of unplanned events, and arise outside of the ordinary course of continuing operations. Restructuring expenses consist of employee severance costs and may also include charges for excess facility space and other contract termination costs. Other charges may include gains or losses on non-controlling strategic equity interests, litigation contingency reserves and gains or losses on the sale or disposition of certain non-strategic assets or product lines. The following table sets forth accrual activity relating to restructuring reserve for the nine months ended June 30, 2015 (dollars in thousands): Personnel Facilities Total Balance at September 30, 2014 $ 3,258 $ 1,468 $ 4,726 Restructuring charges, net 8,461 920 9,381 Cash payments (9,339 ) (1,622 ) (10,961 ) Balance at June 30, 2015 $ 2,380 $ 766 $ 3,146 Restructuring and other charges, net by segment are as follows (dollars in thousands): Three Months Ended June 30, 2015 2014 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 659 $ 634 $ 1,293 $ — $ 1,293 $ 1,811 $ 11 $ 1,822 $ 78 $ 1,900 Mobile and Consumer 3,253 30 3,283 3,322 6,605 1,115 622 1,737 — 1,737 Enterprise 674 — 674 — 674 4,014 — 4,014 — 4,014 Imaging 568 — 568 — 568 309 107 416 — 416 Corporate 1,668 — 1,668 — 1,668 555 — 555 — 555 Total $ 6,822 $ 664 $ 7,486 $ 3,322 $ 10,808 $ 7,804 $ 740 $ 8,544 $ 78 $ 8,622 Nine Months Ended June 30, 2015 2014 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 450 $ 634 $ 1,084 $ — $ 1,084 $ 2,211 $ 11 $ 2,222 $ 78 $ 2,300 Mobile and Consumer 3,140 (142 ) 2,998 3,322 6,320 1,305 622 1,927 — 1,927 Enterprise 963 95 1,058 — 1,058 5,759 — 5,759 — 5,759 Imaging 2,047 333 2,380 — 2,380 440 107 547 — 547 Corporate 1,861 — 1,861 — 1,861 1,182 2,463 3,645 3,000 6,645 Total $ 8,461 $ 920 $ 9,381 $ 3,322 $ 12,703 $ 10,897 $ 3,203 $ 14,100 $ 3,078 $ 17,178 During May 2015, our management approved a restructuring plan, as part of our initiatives to reduce costs and optimize processes, under which we reduced headcount by approximately 200 employees and closed certain excess facility space resulting in a charge of $7.5 million for the three months ended June 30, 2015 . We expect that the remaining severance payments of $2.4 million will be substantially paid by the end of fiscal year 2015. In addition, during the three months ended June 30, 2015 , we have recorded certain other charges that totaled $3.3 million for the impairment of certain long-lived assets as a result of our strategic realignment of our product portfolio. |
Debt and Credit Facilities
Debt and Credit Facilities | 9 Months Ended |
Jun. 30, 2015 | |
Debt Disclosure [Abstract] | |
Debt and Credit Facilities | Debt and Credit Facilities At June 30, 2015 and September 30, 2014 , we had the following borrowing obligations (dollars in thousands): June 30, 2015 September 30, 2014 5.375% Senior Notes due 2020, net of unamortized premium of $4.0 million and $4.6 million, respectively. Effective interest rate 5.28%. $ 1,054,014 $ 1,054,601 2.75% Convertible Debentures due 2031, net of unamortized discount of $43.4 million and $88.8 million, respectively. Effective interest rate 7.43%. 390,400 601,226 1.50% Convertible Debentures due 2035, net of unamortized discount of $62.7 million at June 30, 2015. Effective interest rate 5.50%. 201,237 — Credit Facility, net of unamortized original issue discount of $0.8 million and $1.0 million respectively. 472,924 476,399 Total long-term debt $ 2,118,575 $ 2,132,226 Less: current portion 4,834 4,834 Non-current portion of long-term debt $ 2,113,741 $ 2,127,392 1.50% Convertible Debentures due in 2035 In June 2015, we issued $263.9 million in aggregate principal amount of 1.50% Senior Convertible Debentures due in 2035 (the “2035 Debentures”) in exchange for $256.2 million in aggregate principal amount of our 2.75% Senior Convertible Debentures due in 2031 (the “2031 Debentures”). Total proceeds, net of debt issuance costs, were $253.5 million . The 2035 Debentures were issued at 97.09% of the principal amount, which resulted in a discount of $7.7 million . The 2035 Debentures bear interest at 1.50% per year, payable in cash semi-annually in arrears, beginning on November 1, 2015. In addition to ordinary interest and default additional interest, beginning with the semi-annual interest period commencing on November 1, 2021, contingent interest will accrue during any regular semi-annual interest period where the average trading price of our 2035 Debentures for the ten trading day period immediately preceding the first day of such semi-annual period is greater than or equal to $1,200 per $1,000 principal amount of our 2035 Debentures, in which case, contingent interest will accrue at a rate of 0.50% per annum of such average trading price. The 2035 Debentures mature on November 1, 2035, subject to the right of the holders to require us to redeem the 2035 Debentures on November 1, 2021, 2026, or 2031. The 2035 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 2035 Debentures. The 2035 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries. We account separately for the liability and equity components of the 2035 Debentures in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance requires the carrying amount of the liability component to be estimated by measuring the fair value of a similar liability that does not have an associated conversion feature and record the remainder in stockholders’ equity. At issuance, we allocated $208.6 million to long-term debt, and $55.3 million has been recorded as additional paid-in capital. The aggregate debt discount of $63.0 million is being amortized to interest expense using the effective interest rate method through November 2021. As of June 30, 2015, the ending unamortized deferred debt issuance costs were $2.2 million . If converted, the principal amount of the 2035 Debentures is payable in cash and any amounts payable in excess of the principal amount, will (based on an initial conversion rate, which represents an initial conversion price of approximately $23.26 per share, subject to adjustment) be paid in cash or shares of our common stock, at our election, only in the following circumstances and to the following extent: (i) prior to May 1, 2035, on any date during any fiscal quarter beginning after September 30, 2015 (and only during such fiscal quarter) if the closing sale price of our common stock was more than 130% of the then current conversion price for at least 20 trading days in the period of the 30 consecutive trading days ending on the last trading day of the previous fiscal quarter; (ii) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for $1,000 principal amount of the 2035 Debentures for each day during such five trading-day period was less than 98% of the closing sale price of our common stock multiplied by the then current conversion rate; (iii) upon the occurrence of specified corporate transactions, as described in the indenture for the 2035 Debentures; or (iv) at the option of the holder at any time on or after May 1, 2035. Additionally, we may redeem the 2035 Debentures, in whole or in part, on or after November 5, 2021 for cash at a price equal to 100% of the principal amount of the 2035 Debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. Each holder shall have the right, at such holder’s option, to require us to repurchase all or any portion of the 2035 Debentures held by such holder on November 1, 2021, November 1, 2026, or November 1, 2031 at par plus accrued and unpaid interest. Upon repurchase, we will pay the principal amount in cash and any amounts payable in excess of the principal amount will be paid in cash or shares of our common stock, at our election, with the exception that we may not elect to pay cash in lieu of more than 80% of the number of our common shares we would be obligated to deliver. If we undergo a fundamental change (as described in the indenture for the 2035 Debentures) prior to maturity, holders will have the option to require us to repurchase all or any portion of their debentures for cash at a price equal to 100% of the principal amount of the 2035 Debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. As of June 30, 2015, none of the conversion criteria were met for the 2035 Debentures. If the conversion criteria were met, we could be required to repay all or some of the aggregate principal amount in cash prior to the maturity date. 2.75% Convertible Debentures due in 2031 In June 2015, we entered into separate privately negotiated agreements with certain holders of our 2031 Debentures to exchange, in a private placement, $256.2 million in aggregate principal amount of our 2031 Debentures for approximately $263.9 million in aggregate principal amount of our new 2035 Debentures. In accordance with the authoritative guidance for convertible debt instruments, a loss on extinguishment is equal to the difference between the reacquisition price and the net carrying amount of the extinguished debt for our 2031 Debentures, including any unamortized debt discount or issuance costs, and $17.7 million was recorded in other (expense) income, net. Following the closings of the exchange, $433.8 million in aggregate principal amount of our 2031 Debentures remain outstanding. As of June 30, 2015 and September 30, 2014 the ending unamortized deferred debt issuance costs were $2.6 million and $5.5 million , respectively. As of June 30, 2015 and September 30, 2014 , none of the conversion criteria were met for the 2031 Debentures. If the conversion criteria were met, we could be required to repay all or some of the aggregate principal amount in cash prior to the maturity date. Credit Facility The Credit Facility includes a term loan and a $75.0 million revolving credit line, including letters of credit. The term loans mature on August 7, 2019 and the revolving credit line matures on August 7, 2018. As of June 30, 2015 , there were $5.7 million of letters of credit issued, and there were no other outstanding borrowings under the revolving credit line. Under the terms of the amended and restated credit agreement, interest is payable monthly at a rate equal to the applicable margin plus, at our option, either (a) the base rate which is the corporate base rate of Morgan Stanley, the Administrative Agent, or (b) LIBOR (equal to (i) the British Bankers’ Association Interest Settlement Rates for deposits in U.S. dollars divided by (ii) one minus the statutory reserves applicable to such borrowing). The applicable margin for the borrowings at June 30, 2015 is as follows: Description Base Rate Margin LIBOR Margin Term loans maturing August 2019 1.75% 2.75% Revolving facility due August 2018 0.50% - 0.75% (a) 1.50% - 1.75% (a) (a) The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. At June 30, 2015 , the applicable margin for the term loans was 2.75% , with an effective rate of 2.94% , on the outstanding balance of $473.8 million maturing in August 2019 . We are required to pay a commitment fee for unutilized commitments under the revolving credit facility at a rate ranging from 0.250% to 0.375% per annum, based upon our net leverage ratio. As of June 30, 2015 , the commitment fee rate was 0.375% . The Credit Facility contains covenants including, among other things, covenants that restrict our ability and those of our subsidiaries to incur certain additional indebtedness or issue guarantees, create or permit liens on assets, enter into sale-leaseback transactions, make loans or investments, sell assets, make certain acquisitions, pay dividends, repurchase stock, or merge or consolidate with any entity, and enter into certain transactions with affiliates. The agreement also contains events of default, including failure to make payments of principal or interest, failure to observe covenants, breaches of representations and warranties, defaults under certain other material indebtedness, failure to satisfy material judgments, a change of control and certain insolvency events. As of June 30, 2015 , we were in compliance with the covenants under the Credit Facility. The covenants on our other long-term debt are less restrictive, and as of June 30, 2015 , we were in compliance with the requirements of our other long-term debt. Our obligations under the Credit Facility are unconditionally guaranteed by, subject to certain exceptions, each of our existing and future direct and indirect wholly-owned domestic subsidiaries. The Credit Facility and the guarantees thereof are secured by first priority liens and security interests in the following: 100% of the capital stock of substantially all of our domestic subsidiaries and 65% of the outstanding voting equity interests and 100% of the non-voting equity interests of first-tier foreign subsidiaries, all our material tangible and intangible assets and those of the guarantors, and any present and future intercompany debt. The Credit Facility also contains provisions for mandatory prepayments of outstanding term loans upon receipt of the following, and subject to certain exceptions: 100% of net cash proceeds from asset sales, 100% of net cash proceeds from issuance or incurrence of debt, and 100% of extraordinary receipts. We may voluntarily prepay borrowings under the Credit Facility without premium or penalty other than breakage costs, as defined with respect to LIBOR-based loans. The Credit Facility includes a provision for an annual excess cash flow sweep, as defined in the agreement, payable in the first quarter of each fiscal year, based on the excess cash flow generated in the previous fiscal year. No excess cash flow sweep was required in the first quarter of fiscal year 2015 as no excess cash flow, as defined in the agreement, was generated in fiscal year 2014. At the current time, we are unable to predict the amount of the outstanding principal, if any, that we may be required to repay in future fiscal years pursuant to the excess cash flow sweep provisions. |
Stockholders' Equity (Notes)
Stockholders' Equity (Notes) | 9 Months Ended |
Jun. 30, 2015 | |
Stockholders' Equity Attributable to Parent [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | Stockholders' Equity Share Repurchases On April 29, 2013 , our Board of Directors approved a share repurchase program for up to $500.0 million of our outstanding shares of common stock. On April 29, 2015, our Board of Directors approved an additional $500.0 million under our share repurchase program. We repurchased 16.5 million shares for $242.7 million during the nine months ended June 30, 2015 . Since the commencement of the program, we have repurchased 27.9 million shares for $453.5 million . Approximately $546.5 million remained available for share repurchases as of June 30, 2015 pursuant to our share repurchase program. Under the terms of the share repurchase program, we expect to continue to repurchase shares from time to time through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The timing and the amount of any purchases will be determined by management based on an evaluation of market conditions, capital allocation alternatives, and other factors. The share repurchase program does not require us to acquire any specific number of shares and may be modified, suspended, extended or terminated by us at any time without prior notice. |
Net Loss Per Share
Net Loss Per Share | 9 Months Ended |
Jun. 30, 2015 | |
Earnings Per Share, Basic and Diluted [Abstract] | |
Net (Loss) Income Per Share | Net Loss Per Share Common equivalent shares are excluded from the computation of diluted net loss per share if their effect is anti-dilutive. Potentially dilutive common equivalent shares aggregating to 10.0 million and 12.1 million shares for the three months ended June 30, 2015 and 2014 , respectively, and 10.4 million and 12.1 million shares for the nine months ended June 30, 2015 and 2014 , respectively, have been excluded from the computation of diluted net loss per share because their inclusion would be anti-dilutive. |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Jun. 30, 2015 | |
Share-based Compensation [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation We recognize stock-based compensation expense over the requisite service period. Our share-based awards are accounted for as equity instruments. The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Cost of product and licensing $ 148 $ 238 $ 331 $ 1,200 Cost of professional services and hosting 7,833 10,528 20,185 24,346 Cost of maintenance and support 1,002 1,290 2,576 2,480 Research and development 9,210 12,960 26,387 33,703 Selling and marketing 11,760 13,656 32,176 39,110 General and administrative 11,748 16,710 38,317 46,702 Total $ 41,701 $ 55,382 $ 119,972 $ 147,541 Stock Options The table below summarizes activity relating to stock options for the nine months ended June 30, 2015 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (a) Outstanding at September 30, 2014 3,723,342 $ 13.46 Exercised (327,844 ) $ 10.33 Forfeited (892 ) $ 20.04 Expired (30,976 ) $ 19.30 Outstanding at June 30, 2015 3,363,630 $ 13.71 1.5 years $ 12.9 million Exercisable at June 30, 2015 3,362,385 $ 13.71 1.5 years $ 12.9 million Exercisable at June 30, 2014 3,749,438 $ 13.45 2.5 years $ 20.0 million (a) The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on June 30, 2015 ( $17.51 ) and the exercise price of the underlying options. The weighted-average intrinsic value of stock options exercised during the nine months ended June 30, 2015 and 2014 was $2.1 million and $3.1 million , respectively. Restricted Units Restricted units are not included in issued and outstanding common stock until the shares are vested and released. The purchase price for vested restricted units is $0.001 per share. The table below summarizes activity relating to restricted units for the nine months ended June 30, 2015 : Number of Shares Underlying Restricted Units — Contingent Awards Number of Shares Underlying Restricted Units — Time-Based Awards Outstanding at September 30, 2014 5,726,385 8,349,107 Granted 1,771,610 7,375,369 Earned/released (1,891,051 ) (6,493,760 ) Forfeited (646,222 ) (552,253 ) Outstanding at June 30, 2015 4,960,722 8,678,463 Weighted average remaining recognition period of outstanding restricted units 1.4 years 1.7 years Unearned stock-based compensation expense of outstanding restricted units $65.2 million $94.5 million Aggregate intrinsic value of outstanding restricted units (a) $86.9 million $152.0 million (a) The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on June 30, 2015 ( $17.51 ) and the purchase price of the underlying Restricted Units. A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all restricted units vested during the periods noted is as follows: Nine Months Ended June 30, 2015 2014 Weighted-average grant-date fair value per share $ 15.36 $ 15.39 Total intrinsic value of shares vested (in millions) $ 125.1 $ 82.7 Restricted Stock Awards Restricted stock awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to restricted stock awards for the nine months ended June 30, 2015 : Number of Shares Underlying Restricted Stock Weighted Average Grant Date Fair Value Outstanding at September 30, 2014 750,000 $ 21.28 Vested (250,000 ) $ 25.80 Outstanding at June 30, 2015 500,000 $ 19.01 Weighted average remaining recognition period of outstanding restricted stock awards 0.3 years Unearned stock-based compensation expense of outstanding restricted stock awards $2.2 million Aggregate intrinsic value of outstanding restricted stock awards $8.8 million A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all restricted stock awards vested during the periods noted is as follows: Nine Months Ended June 30, 2015 2014 Weighted-average grant-date fair value per share $ — $ 15.71 Total intrinsic value of shares vested (in millions) $ 3.9 $ 3.9 |
Income Taxes
Income Taxes | 9 Months Ended |
Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The components of loss before income taxes are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Domestic $ (65,222 ) $ (51,233 ) $ (166,157 ) $ (172,860 ) Foreign 32,365 3,945 85,580 40,304 Loss before income taxes $ (32,857 ) $ (47,288 ) $ (80,577 ) $ (132,556 ) The components of provision from income taxes are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Domestic $ 1,728 $ 4,710 $ 11,414 $ 8,505 Foreign 4,805 2,249 11,992 7,826 Provision for income taxes $ 6,533 $ 6,959 $ 23,406 $ 16,331 Effective tax rate (19.9 )% (14.7 )% (29.0 )% (12.3 )% The effective income tax rate was (19.9)% and (29.0)% for the three and nine months ended June 30, 2015 , respectively. Our current effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to current period losses in the U.S. that require an additional valuation allowance that provide no benefit to the provision and our earnings in foreign operations that are subject to a significantly lower tax rate than the U.S. statutory tax rate, driven primarily by our subsidiaries in Ireland. In addition, the three and nine months ended June 30, 2015 also include $3.5 million and $10.6 million , respectively, of deferred tax expense related to tax deductible goodwill in the U.S., offset by the release of $2.1 million in reserves for the settlement of a state tax audit during the three months ended June 30, 2015 . Our effective income tax rate is based upon the income for the year, the composition of income in different countries, changes relating to valuation allowances for certain countries if and as necessary, and adjustments, if any, for potential tax consequences resulting from audits or other tax contingencies. Our aggregate income tax rate in foreign jurisdictions is lower than our income tax rate in the United States. Our effective tax rate may be adversely affected by earnings being lower than anticipated in countries where we have lower statutory tax rates and higher than anticipated in countries where we have higher statutory tax rates. At June 30, 2015 and September 30, 2014 , we had gross tax effected unrecognized tax benefits of $21.9 million and $21.2 million , respectively, and is included in other long term liabilities. If these benefits were recognized, they would favorably impact the effective tax rate. We do no t expect a significant change in the amount of unrecognized tax benefits within the next 12 months. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Jun. 30, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation and Other Claims Similar to many companies in the software industry, we are involved in a variety of claims, demands, suits, investigations and proceedings that arise from time to time relating to matters incidental to the ordinary course of our business, including actions with respect to contracts, intellectual property, employment, benefits and securities matters. We have estimated the amount of probable losses that may result from all currently pending matters, and such amounts are reflected in our consolidated financial statements. These recorded amounts are not material to our consolidated financial position or results of operations and no additional material losses related to these pending matters are reasonably possible. While it is not possible to predict the outcome of these matters with certainty, we do not expect the results of any of these actions to have a material adverse effect on our results of operations or financial position. However, each of these matters is subject to uncertainties, the actual losses may prove to be larger or smaller than the accruals reflected in our consolidated financial statements, and we could incur judgments or enter into settlements of claims that could adversely affect our financial position, results of operations or cash flows. Guarantees and Other We include indemnification provisions in the contracts we enter into with customers and business partners. Generally, these provisions require us to defend claims arising out of our products’ infringement of third-party intellectual property rights, breach of contractual obligations and/or unlawful or otherwise culpable conduct. The indemnity obligations generally cover damages, costs and attorneys’ fees arising out of such claims. In most, but not all cases, our total liability under such provisions is limited to either the value of the contract or a specified, agreed upon amount. In some cases our total liability under such provisions is unlimited. In many, but not all cases, the term of the indemnity provision is perpetual. While the maximum potential amount of future payments we could be required to make under all the indemnification provisions is unlimited, we believe the estimated fair value of these provisions is minimal due to the low frequency with which these provisions have been triggered. We indemnify our directors and officers to the fullest extent permitted by Delaware law, which provides among other things, indemnification to directors and officers for expenses, judgments, fines, penalties and settlement amounts incurred by such persons in their capacity as a director or officer of the company, regardless of whether the individual is serving in any such capacity at the time the liability or expense is incurred. Additionally, in connection with certain acquisitions we have agreed to indemnify the former officers and members of the boards of directors of those companies, on similar terms as described above, for a period of six years from the acquisition date. In certain cases we purchase director and officer insurance policies related to these obligations, which fully cover the six year period. To the extent that we do not purchase a director and officer insurance policy for the full period of any contractual indemnification, and such directors and officers do not have coverage under separate insurance policies, we would be required to pay for costs incurred, if any, as described above. |
Segment and Geographic Informat
Segment and Geographic Information and Significant Customers | 9 Months Ended |
Jun. 30, 2015 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information and Significant Customers | Segment and Geographic Information We operate in, and report financial information for, the following four reportable segments: Healthcare, Mobile and Consumer, Enterprise, and Imaging. Segment profit is an important measure used for evaluating performance and for decision-making purposes and reflects the direct controllable costs of each segment together with an allocation of sales and corporate marketing expenses, and certain research and development project costs that benefit multiple product offerings. Segment profit represents income from operations excluding stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, costs associated with intellectual property collaboration agreements, other income (expense), net and certain unallocated corporate expenses. In October 2014, we realigned certain of our product offerings which were previously reported in the Mobile and Consumer segment into the Enterprise segment. Accordingly, the segment results in prior periods have been reclassified to conform to the current period segment reporting presentation. We do not track our assets by operating segment; consequently, it is not practical to show assets or depreciation by segment. The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): Three Months Ended Nine Months Ended June 30, June 30, 2015 2014 2015 2014 Segment revenues (a) : Healthcare $ 236,855 $ 240,099 $ 696,439 $ 704,382 Mobile and Consumer 108,577 106,978 332,614 326,690 Enterprise 86,966 87,286 260,911 269,020 Imaging 56,258 52,451 175,785 166,740 Total segment revenues 488,656 486,814 1,465,749 1,466,832 Acquisition-related revenues (10,717 ) (11,310 ) (38,732 ) (45,695 ) Total consolidated revenues 477,939 475,504 1,427,017 1,421,137 Segment profit: Healthcare 81,846 84,916 239,966 254,853 Mobile and Consumer 26,959 19,677 72,468 48,507 Enterprise 24,895 18,346 68,909 59,019 Imaging 21,762 16,887 63,770 60,271 Total segment profit 155,462 139,826 445,113 422,650 Corporate expenses and other, net (31,226 ) (25,292 ) (102,344 ) (86,624 ) Acquisition-related revenues and cost of revenues adjustment (10,198 ) (10,450 ) (36,576 ) (42,319 ) Stock-based compensation (41,701 ) (55,382 ) (119,972 ) (147,541 ) Amortization of intangible assets (42,147 ) (42,293 ) (125,064 ) (126,872 ) Acquisition-related costs, net (2,423 ) (9,110 ) (13,702 ) (18,710 ) Restructuring and other charges, net (10,808 ) (8,622 ) (12,703 ) (17,178 ) Costs associated with IP collaboration agreements (2,625 ) (4,937 ) (8,501 ) (14,811 ) Other expense, net (47,191 ) (31,028 ) (106,828 ) (101,151 ) Loss before income taxes $ (32,857 ) $ (47,288 ) $ (80,577 ) $ (132,556 ) (a) Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that will not be fully recognized in accordance with authoritative guidance for the purchase accounting of business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. There were no countries outside of the United States that provided greater than 10% of our total revenues. Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): Three Months Ended Nine Months Ended June 30, June 30, 2015 2014 2015 2014 United States $ 352,033 $ 350,363 $ 1,052,155 $ 1,040,135 International 125,906 125,141 374,862 381,002 Total revenues $ 477,939 $ 475,504 $ 1,427,017 $ 1,421,137 |
Summary of Significant Accoun23
Summary of Significant Accounting Policies Recently Issued Accounting Pronouncements (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Recently Issued Accounting Pronouncements [Abstract] | |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board and are adopted by us as of the specified effective dates. Unless otherwise discussed, such pronouncements did not have or will not have a significant impact on our condensed consolidated financial position, results of operations and cash flows or do not apply to our operations. In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs" ("ASU 2015-03"). The amendments in the ASU 2015-03 require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU 2015-03 is effective for us in the first quarter of fiscal year 2017, with early adoption permitted. ASU 2015-03 should be applied on a retrospective basis to each individual period presented. Upon implementation, the change in reporting debt issuance costs will require us to reclassify our deferred financing costs from an asset to a reduction of the reported debt balance. ASU 2015-03 will reduce our assets and liabilities but will have no impact on our shareholders' equity, results of operations or cash flows. In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Amendments to the Consolidation Analysis” ("ASU 2015-02"). The amendments in ASU 2015-02 provide guidance on evaluating whether a company should consolidate certain legal entities. In accordance with the guidance, all legal entities are subject to reevaluation under the revised consolidation model. ASU 2015-02 is effective for us in the first quarter of fiscal year 2017 with early adoption permitted. We do not believe that ASU 2015-02 will have a material impact on our consolidated financial statements. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, "Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern" ("ASU 2014-15"), to provide guidance on management's responsibility in evaluating whether there is substantial doubt about a company's ability to continue as a going concern and to provide related footnote disclosures. ASU 2014-15 is effective for us in the first quarter of fiscal year 2017, with early adoption permitted. We do not believe that ASU 2014-15 will have a material impact on our consolidated financial statements. In June 2014, the FASB issued Accounting Standards Update No. 2014-12, " Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period" ("ASU 2014-12"). ASU 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in ASC 718, "Compensation - Stock Compensation," as it relates to such awards. ASU 2014-12 is effective for us in our first quarter of fiscal year 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. We are currently evaluating the impact of our pending adoption on ASU 2014-12 on our consolidated financial statements. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, "Revenue from Contracts with Customers: Topic 606" ("ASU 2014-09"), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for us in our first quarter of fiscal year 2018 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU 2014-09. We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity" ("ASU 2014-08"), to change the criteria for determining which disposals can be presented as discontinued operations and enhanced the related disclosure requirements. ASU 2014-08 is effective for us on a prospective basis in our first quarter of fiscal year 2016 with early adoption permitted for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued. We are currently evaluating the impact of our pending adoption of ASU 2014-08 on our consolidated financial statements. |
Business Acquisitions (Tables)
Business Acquisitions (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Business Combinations [Abstract] | |
Components of Acquisition-Related Costs, Net | The components of acquisition-related costs, net are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Transition and integration costs $ 2,923 $ 5,612 $ 9,160 $ 14,041 Professional service fees 1,431 3,363 7,117 9,101 Acquisition-related adjustments (1,931 ) 135 (2,575 ) (4,432 ) Total $ 2,423 $ 9,110 $ 13,702 $ 18,710 Included in acquisition-related adjustments for the nine months ended June 30, 2014 , is income of $7.7 million related to the elimination of contingent liabilities established in the original allocation of purchase price for acquisitions closed in fiscal year 2008, following the expiration of the applicable statute of limitations. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amount of Goodwill and Intangible Assets | The changes in the carrying amount of goodwill and intangible assets for the nine months ended June 30, 2015 , are as follows (dollars in thousands): Goodwill Intangible Assets Balance at September 30, 2014 $ 3,410,893 $ 915,483 Acquisitions 22,552 65,622 Dispositions — (2,806 ) Purchase accounting adjustments (1,237 ) (554 ) Amortization — (125,064 ) Effect of foreign currency translation (39,364 ) (5,476 ) Balance at June 30, 2015 $ 3,392,844 $ 847,205 |
Financial Instruments and Hed26
Financial Instruments and Hedging Activities (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
ScheduleOfOutstandingSharesSubjectToSecurityPriceGuarantees [Table Text Block] | We have no outstanding shares subject to security price guarantees at June 30, 2015 . |
Quantitative Summary of Fair Value of Derivative Instruments | The following table provides a quantitative summary of the fair value of our derivative instruments as of June 30, 2015 and September 30, 2014 (dollars in thousands): Derivatives Not Designated as Hedges: Balance Sheet Classification Fair Value June 30, 2015 September 30, 2014 Foreign currency contracts Accrued expenses and other current liabilities $ (550 ) $ (272 ) Security Price Guarantees Accrued expenses and other current liabilities — (135 ) Net fair value of non-hedge derivative instruments $ (550 ) $ (407 ) |
Summarized Activity of Derivative Instruments | The following tables summarize the activity of derivative instruments for the three and nine months ended June 30, 2015 and 2014 (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, Derivatives Not Designated as Hedges Location of Gain (Loss) Recognized in Income 2015 2014 2015 2014 Foreign currency contracts Other income (expense), net $ 3,078 $ 2,965 $ (16,019 ) $ 9,338 Security price guarantees Other income (expense), net $ 334 $ 650 $ (204 ) $ (3,572 ) |
Fair Value Measures (Tables)
Fair Value Measures (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis at June 30, 2015 and September 30, 2014 consisted of (dollars in thousands): June 30, 2015 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 245,742 $ — $ — $ 245,742 US government agency securities (a) 1,000 — — 1,000 Time deposits (b) — 57,378 — 57,378 Commercial paper, $3,784 at cost (b) — 3,788 — 3,788 Corporate notes and bonds, $46,139 at cost (b) — 46,142 — 46,142 Total assets at fair value $ 246,742 $ 107,308 $ — $ 354,050 Liabilities: Foreign currency exchange contracts (b) $ — $ (550 ) $ — $ (550 ) Contingent acquisition payments (d) — — (20,187 ) (20,187 ) Total liabilities at fair value $ — $ (550 ) $ (20,187 ) $ (20,737 ) September 30, 2014 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 407,749 $ — $ — $ 407,749 US government agency securities (a) 1,000 — — 1,000 Time deposits (b) — 46,604 — 46,604 Total assets at fair value $ 408,749 $ 46,604 $ — $ 455,353 Liabilities: Foreign currency exchange contracts (b) $ — $ (272 ) $ — $ (272 ) Security price guarantees (c) — (135 ) — (135 ) Contingent acquisition payments (d) — — (6,864 ) (6,864 ) Total liabilities at fair value $ — $ (407 ) $ (6,864 ) $ (7,271 ) (a) Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. (b) The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. (c) The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. (d) The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. |
Changes in Fair Value of Contingent Earn-Out Liabilities | The changes in the fair value of contingent acquisition payment liabilities are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2015 Balance at beginning of period $ 3,931 $ 6,864 Earn-out liabilities established at time of acquisition 15,997 16,082 Payments upon settlement (174 ) (3,112 ) Adjustments to fair value included in acquisition-related costs, net 433 353 Balance at end of period $ 20,187 $ 20,187 |
Accrued Expenses and Other Cu28
Accrued Expenses and Other Current Liabilities (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (dollars in thousands): June 30, 2015 September 30, 2014 Compensation $ 107,547 $ 146,730 Cost of revenue related liabilities 25,331 22,340 Accrued interest payable 23,435 15,092 Professional fees 9,307 10,852 Sales and marketing incentives 7,847 10,188 Sales and other taxes payable 6,024 9,367 Acquisition costs and liabilities 5,505 9,307 Facilities related liabilities 5,514 5,720 Liability for unsettled share repurchases 4,463 — Other 8,574 11,683 Total $ 203,547 $ 241,279 |
Deferred Revenue (Tables)
Deferred Revenue (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Deferred Revenue [Abstract] | |
Deferred Revenue | Deferred revenue consisted of the following (dollars in thousands): June 30, 2015 September 30, 2014 Current liabilities: Deferred maintenance revenue $ 153,941 $ 140,737 Unearned revenue 173,795 157,488 Total current deferred revenue $ 327,736 $ 298,225 Long-term liabilities: Deferred maintenance revenue $ 61,505 $ 60,398 Unearned revenue 258,390 189,481 Total long-term deferred revenue $ 319,895 $ 249,879 |
Restructuring and Other Charg30
Restructuring and Other Charges, net (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Restructuring and Related Activities [Abstract] | |
Accrual Activity Relating to Restructuring and Other Charges | The following table sets forth accrual activity relating to restructuring reserve for the nine months ended June 30, 2015 (dollars in thousands): Personnel Facilities Total Balance at September 30, 2014 $ 3,258 $ 1,468 $ 4,726 Restructuring charges, net 8,461 920 9,381 Cash payments (9,339 ) (1,622 ) (10,961 ) Balance at June 30, 2015 $ 2,380 $ 766 $ 3,146 |
Restructuring and Other Charges, Net by Segment | Restructuring and other charges, net by segment are as follows (dollars in thousands): Three Months Ended June 30, 2015 2014 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 659 $ 634 $ 1,293 $ — $ 1,293 $ 1,811 $ 11 $ 1,822 $ 78 $ 1,900 Mobile and Consumer 3,253 30 3,283 3,322 6,605 1,115 622 1,737 — 1,737 Enterprise 674 — 674 — 674 4,014 — 4,014 — 4,014 Imaging 568 — 568 — 568 309 107 416 — 416 Corporate 1,668 — 1,668 — 1,668 555 — 555 — 555 Total $ 6,822 $ 664 $ 7,486 $ 3,322 $ 10,808 $ 7,804 $ 740 $ 8,544 $ 78 $ 8,622 Nine Months Ended June 30, 2015 2014 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 450 $ 634 $ 1,084 $ — $ 1,084 $ 2,211 $ 11 $ 2,222 $ 78 $ 2,300 Mobile and Consumer 3,140 (142 ) 2,998 3,322 6,320 1,305 622 1,927 — 1,927 Enterprise 963 95 1,058 — 1,058 5,759 — 5,759 — 5,759 Imaging 2,047 333 2,380 — 2,380 440 107 547 — 547 Corporate 1,861 — 1,861 — 1,861 1,182 2,463 3,645 3,000 6,645 Total $ 8,461 $ 920 $ 9,381 $ 3,322 $ 12,703 $ 10,897 $ 3,203 $ 14,100 $ 3,078 $ 17,178 |
Debt and Credit Facilities (Tab
Debt and Credit Facilities (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Debt Disclosure [Abstract] | |
Borrowing Obligations and Applicable Margin for Borrowings | At June 30, 2015 and September 30, 2014 , we had the following borrowing obligations (dollars in thousands): June 30, 2015 September 30, 2014 5.375% Senior Notes due 2020, net of unamortized premium of $4.0 million and $4.6 million, respectively. Effective interest rate 5.28%. $ 1,054,014 $ 1,054,601 2.75% Convertible Debentures due 2031, net of unamortized discount of $43.4 million and $88.8 million, respectively. Effective interest rate 7.43%. 390,400 601,226 1.50% Convertible Debentures due 2035, net of unamortized discount of $62.7 million at June 30, 2015. Effective interest rate 5.50%. 201,237 — Credit Facility, net of unamortized original issue discount of $0.8 million and $1.0 million respectively. 472,924 476,399 Total long-term debt $ 2,118,575 $ 2,132,226 Less: current portion 4,834 4,834 Non-current portion of long-term debt $ 2,113,741 $ 2,127,392 The applicable margin for the borrowings at June 30, 2015 is as follows: Description Base Rate Margin LIBOR Margin Term loans maturing August 2019 1.75% 2.75% Revolving facility due August 2018 0.50% - 0.75% (a) 1.50% - 1.75% (a) (a) The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Share-based Compensation [Abstract] | |
Stock Based Compensation Included in Consolidated Statements of Operations | The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Cost of product and licensing $ 148 $ 238 $ 331 $ 1,200 Cost of professional services and hosting 7,833 10,528 20,185 24,346 Cost of maintenance and support 1,002 1,290 2,576 2,480 Research and development 9,210 12,960 26,387 33,703 Selling and marketing 11,760 13,656 32,176 39,110 General and administrative 11,748 16,710 38,317 46,702 Total $ 41,701 $ 55,382 $ 119,972 $ 147,541 |
Summary of Stock Options Activity | The table below summarizes activity relating to stock options for the nine months ended June 30, 2015 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (a) Outstanding at September 30, 2014 3,723,342 $ 13.46 Exercised (327,844 ) $ 10.33 Forfeited (892 ) $ 20.04 Expired (30,976 ) $ 19.30 Outstanding at June 30, 2015 3,363,630 $ 13.71 1.5 years $ 12.9 million Exercisable at June 30, 2015 3,362,385 $ 13.71 1.5 years $ 12.9 million Exercisable at June 30, 2014 3,749,438 $ 13.45 2.5 years $ 20.0 million (a) The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on June 30, 2015 ( $17.51 ) and the exercise price of the underlying options. |
Summary of Activity Relating to Restricted Units and Restricted Stock Awards | Restricted stock awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to restricted stock awards for the nine months ended June 30, 2015 : Number of Shares Underlying Restricted Stock Weighted Average Grant Date Fair Value Outstanding at September 30, 2014 750,000 $ 21.28 Vested (250,000 ) $ 25.80 Outstanding at June 30, 2015 500,000 $ 19.01 Weighted average remaining recognition period of outstanding restricted stock awards 0.3 years Unearned stock-based compensation expense of outstanding restricted stock awards $2.2 million Aggregate intrinsic value of outstanding restricted stock awards $8.8 million The table below summarizes activity relating to restricted units for the nine months ended June 30, 2015 : Number of Shares Underlying Restricted Units — Contingent Awards Number of Shares Underlying Restricted Units — Time-Based Awards Outstanding at September 30, 2014 5,726,385 8,349,107 Granted 1,771,610 7,375,369 Earned/released (1,891,051 ) (6,493,760 ) Forfeited (646,222 ) (552,253 ) Outstanding at June 30, 2015 4,960,722 8,678,463 Weighted average remaining recognition period of outstanding restricted units 1.4 years 1.7 years Unearned stock-based compensation expense of outstanding restricted units $65.2 million $94.5 million Aggregate intrinsic value of outstanding restricted units (a) $86.9 million $152.0 million (a) The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on June 30, 2015 ( $17.51 ) and the purchase price of the underlying Restricted Units. |
Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units and Restricted Stock Awards Vested | A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all restricted stock awards vested during the periods noted is as follows: Nine Months Ended June 30, 2015 2014 Weighted-average grant-date fair value per share $ — $ 15.71 Total intrinsic value of shares vested (in millions) $ 3.9 $ 3.9 A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all restricted units vested during the periods noted is as follows: Nine Months Ended June 30, 2015 2014 Weighted-average grant-date fair value per share $ 15.36 $ 15.39 Total intrinsic value of shares vested (in millions) $ 125.1 $ 82.7 |
Income Taxes (Tables)
Income Taxes (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | |
Components of Benefit from Income Taxes | The components of loss before income taxes are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Domestic $ (65,222 ) $ (51,233 ) $ (166,157 ) $ (172,860 ) Foreign 32,365 3,945 85,580 40,304 Loss before income taxes $ (32,857 ) $ (47,288 ) $ (80,577 ) $ (132,556 ) The components of provision from income taxes are as follows (dollars in thousands): Three Months Ended June 30, Nine Months Ended June 30, 2015 2014 2015 2014 Domestic $ 1,728 $ 4,710 $ 11,414 $ 8,505 Foreign 4,805 2,249 11,992 7,826 Provision for income taxes $ 6,533 $ 6,959 $ 23,406 $ 16,331 Effective tax rate (19.9 )% (14.7 )% (29.0 )% (12.3 )% |
Segment and Geographic Inform34
Segment and Geographic Information and Significant Customers (Tables) | 9 Months Ended |
Jun. 30, 2015 | |
Segment Reporting [Abstract] | |
Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes | The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): Three Months Ended Nine Months Ended June 30, June 30, 2015 2014 2015 2014 Segment revenues (a) : Healthcare $ 236,855 $ 240,099 $ 696,439 $ 704,382 Mobile and Consumer 108,577 106,978 332,614 326,690 Enterprise 86,966 87,286 260,911 269,020 Imaging 56,258 52,451 175,785 166,740 Total segment revenues 488,656 486,814 1,465,749 1,466,832 Acquisition-related revenues (10,717 ) (11,310 ) (38,732 ) (45,695 ) Total consolidated revenues 477,939 475,504 1,427,017 1,421,137 Segment profit: Healthcare 81,846 84,916 239,966 254,853 Mobile and Consumer 26,959 19,677 72,468 48,507 Enterprise 24,895 18,346 68,909 59,019 Imaging 21,762 16,887 63,770 60,271 Total segment profit 155,462 139,826 445,113 422,650 Corporate expenses and other, net (31,226 ) (25,292 ) (102,344 ) (86,624 ) Acquisition-related revenues and cost of revenues adjustment (10,198 ) (10,450 ) (36,576 ) (42,319 ) Stock-based compensation (41,701 ) (55,382 ) (119,972 ) (147,541 ) Amortization of intangible assets (42,147 ) (42,293 ) (125,064 ) (126,872 ) Acquisition-related costs, net (2,423 ) (9,110 ) (13,702 ) (18,710 ) Restructuring and other charges, net (10,808 ) (8,622 ) (12,703 ) (17,178 ) Costs associated with IP collaboration agreements (2,625 ) (4,937 ) (8,501 ) (14,811 ) Other expense, net (47,191 ) (31,028 ) (106,828 ) (101,151 ) Loss before income taxes $ (32,857 ) $ (47,288 ) $ (80,577 ) $ (132,556 ) (a) Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that will not be fully recognized in accordance with authoritative guidance for the purchase accounting of business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. |
Classification of Revenue By Major Geographic Areas | Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): Three Months Ended Nine Months Ended June 30, June 30, 2015 2014 2015 2014 United States $ 352,033 $ 350,363 $ 1,052,155 $ 1,040,135 International 125,906 125,141 374,862 381,002 Total revenues $ 477,939 $ 475,504 $ 1,427,017 $ 1,421,137 |
Business Acquisitions (Summary
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Detail) - Other Acquisitions [Member] - USD ($) $ in Millions | 9 Months Ended | 12 Months Ended |
Jun. 30, 2015 | Sep. 30, 2014 | |
Business Acquisition [Line Items] | ||
Payments to Acquire Businesses, Gross | $ 47.9 | $ 258.3 |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Maximum Unlimited | 19,941,326 | |
Business Acquisition, Contingent Consideration, Fair Value | $ 16.1 | |
Allocation of the purchase consideration: | ||
Goodwill | 22.6 | 139.4 |
Identifiable intangible assets | $ 35.8 | $ 134.5 |
Weighted average life | 6 years 7 months | 10 years 2 months |
Business Acquisitions (Addition
Business Acquisitions (Additional Information) (Detail) - USD ($) $ in Millions | 9 Months Ended | 12 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | Sep. 30, 2014 | |
Business Acquisition [Line Items] | |||
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $ 36 | ||
Business Combination Acquisition Related Adjustments | $ 7.7 | ||
Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions | 1 year | ||
Other Acquisitions [Member] | |||
Business Acquisition [Line Items] | |||
Payments to Acquire Businesses, Gross | $ 47.9 | $ 258.3 | |
Goodwill | 22.6 | 139.4 | |
Identifiable intangible assets | $ 35.8 | $ 134.5 | |
Weighted average life | 6 years 7 months | 10 years 2 months | |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Maximum Unlimited | 19,941,326 | ||
Business Acquisition, Contingent Consideration, Fair Value | $ 16.1 |
Business Acquisitions (Componen
Business Acquisitions (Components of Acquisition-Related Costs, Net) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Business Acquisition [Line Items] | ||||
Business Combination Acquisition Related Adjustments | $ 7,700 | |||
Transition and integration costs | $ 2,923 | $ 5,612 | $ 9,160 | 14,041 |
Professional service fees | 1,431 | 3,363 | 7,117 | 9,101 |
Business Combination Acquisition Related Adjustments | (1,931) | 135 | (2,575) | (4,432) |
Business Combination, Acquisition Related Costs | $ 2,423 | $ 9,110 | $ 13,702 | $ 18,710 |
Changes in Carrying Amount of G
Changes in Carrying Amount of Goodwill and Intangible Assets (Detail) - USD ($) $ in Thousands | 1 Months Ended | 9 Months Ended |
Oct. 31, 2014 | Jun. 30, 2015 | |
Goodwill [Roll Forward] | ||
Balance at September 30, 2013 | $ 3,410,893 | $ 3,410,893 |
Acquisitions | 22,552 | |
Dispositions | 0 | |
Purchase accounting adjustments | (1,237) | |
Amortization | 0 | |
Effect of foreign currency translation | (39,364) | |
Balance at June 30, 2015 | 3,392,844 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Balance at September 30, 2014 | 915,483 | 915,483 |
Acquisitions | 65,622 | |
Dispositions | (2,806) | |
Purchase accounting adjustments | (554) | |
Amortization | (125,064) | |
Effect of foreign currency translation | (5,476) | |
Balance at June 30, 2015 | $ 847,205 | |
Dragon Consumer Reporting Unit [Member] | ||
Reporting Unit [Line Items] | ||
Goodwill, Transfers | 29,900 | |
Enterprise Reporting Unit [Member] | ||
Reporting Unit [Line Items] | ||
Goodwill, Transfers | $ 10,500 |
Financial Instruments and Hed39
Financial Instruments and Hedging Activities (Additional Information) (Detail) - USD ($) $ in Millions | 9 Months Ended | |
Jun. 30, 2015 | Sep. 30, 2014 | |
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Estimated fair value of long-term debt | $ 2,243.4 | $ 2,179.2 |
Long-term debt, face value | 2,221.4 | 2,217.4 |
Derivatives Not Designated as Hedges | ||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Derivative, Notional Amount | $ 161.9 | $ 283.1 |
Derivatives Not Designated as Hedges | Maximum | ||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Term of foreign currency forward contracts | 90 days |
Financial Instruments and Hed40
Financial Instruments and Hedging Activities (Quantitative Summary of Fair Value of Derivative Instruments) (Detail) - USD ($) $ in Thousands | Jun. 30, 2015 | Sep. 30, 2014 |
Derivatives, Fair Value [Line Items] | ||
Net asset (liability) value of non-hedged derivative instruments | $ (550) | $ (407) |
Foreign currency contracts | Accrued Expenses And Other Current Liabilities [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | (550) | (272) |
Security Price Guarantees | Accrued Expenses And Other Current Liabilities [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | $ 0 | $ (135) |
Financial Instruments and Hed41
Financial Instruments and Hedging Activities (Summarized Activity of Derivative Instruments) (Detail) - Derivatives Not Designated as Hedges - Other income (expense), net - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Foreign currency contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Amount of Gain (Loss) Recognized in Income | $ 3,078 | $ 2,965 | $ (16,019) | $ 9,338 |
Security price guarantees | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Amount of Gain (Loss) Recognized in Income | $ 334 | $ 650 | $ (204) | $ (3,572) |
Fair Value Measures (Assets and
Fair Value Measures (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Detail) - USD ($) | 9 Months Ended | ||
Jun. 30, 2015 | Sep. 30, 2014 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Document Period End Date | Jun. 30, 2015 | ||
Fair Value, Measurements, Recurring | |||
Assets: | |||
Money market funds | [1] | $ 245,742,000 | $ 407,749,000 |
US government agency securities | [1] | 1,000,000 | 1,000,000 |
Bank Time Deposits, Fair Value Disclosure | 57,378,000 | 46,604,000 | |
Commercial Paper, Fair value | 3,788,000 | ||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 46,142,000 | ||
Total assets at fair value | 354,050,000 | 455,353,000 | |
Liabilities: | |||
Foreign Currency Contracts, Liability, Fair Value Disclosure | [2] | (550,000) | (272,000) |
Security price guarantees | [3] | (135,000) | |
Contingent earn-out | [4] | (20,187,000) | (6,864,000) |
Total liabilities at fair value | (20,737,000) | (7,271,000) | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | |||
Assets: | |||
Money market funds | 245,742,000 | 407,749,000 | |
US government agency securities | 1,000,000 | 1,000,000 | |
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | |
Commercial Paper, Fair value | 0 | ||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 0 | ||
Total assets at fair value | 246,742,000 | 408,749,000 | |
Interest Rate Derivative Liabilities, at Fair Value | 0 | ||
Liabilities: | |||
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | ||
Security price guarantees | 0 | ||
Contingent earn-out | 0 | 0 | |
Total liabilities at fair value | 0 | 0 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | |||
Assets: | |||
Money market funds | 0 | 0 | |
US government agency securities | 0 | 0 | |
Bank Time Deposits, Fair Value Disclosure | 57,378,000 | 46,604,000 | |
Commercial Paper, Fair value | 3,788,000 | ||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 46,142,000 | ||
Total assets at fair value | 107,308,000 | 46,604,000 | |
Liabilities: | |||
Foreign Currency Contracts, Liability, Fair Value Disclosure | (550,000) | (272,000) | |
Security price guarantees | (135,000) | ||
Contingent earn-out | 0 | 0 | |
Total liabilities at fair value | (550,000) | (407,000) | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | |||
Assets: | |||
Money market funds | 0 | 0 | |
US government agency securities | 0 | 0 | |
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | |
Commercial Paper, Fair value | 0 | ||
Financial Instruments, Owned, Corporate Debt, at Fair Value | 0 | ||
Total assets at fair value | 0 | 0 | |
Interest Rate Derivative Liabilities, at Fair Value | 0 | ||
Liabilities: | |||
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | ||
Security price guarantees | 0 | ||
Contingent earn-out | (20,187,000) | (6,864,000) | |
Total liabilities at fair value | (20,187,000) | $ (6,864,000) | |
Corporate Debt Securities [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Available-for-sale Securities, Amortized Cost Basis | 46,139,000 | ||
Commercial Paper [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Available-for-sale Securities, Amortized Cost Basis | $ 3,784,000 | ||
Commercial paper, corporate notes and bonds [Member] | |||
Liabilities: | |||
Available for sale Securities, Weighted Average Maturity | 1 year 6 months 23 days | ||
[1] | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | ||
[2] | The fair values of our time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | ||
[3] | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | ||
[4] | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. |
Fair Value Measures (Changes in
Fair Value Measures (Changes in Fair Value of Contingent Earn-Out Liabilities) (Detail) - Jun. 30, 2015 - USD ($) $ in Thousands | Total | Total |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
Balance at beginning of period | $ 3,931 | $ 6,864 |
Earn-out liabilities established at time of acquisition | 15,997 | 16,082 |
Adjustments to fair value included in aquisition-related costs, net | 433 | 353 |
Payments upon settlement | (174) | (3,112) |
Balance at end of period | 20,187 | 20,187 |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $ 36,000 | $ 36,000 |
Accrued Expenses and Other Cu44
Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands | Jun. 30, 2015 | Sep. 30, 2014 |
Payables and Accruals [Abstract] | ||
Compensation | $ 107,547 | $ 146,730 |
Cost of revenue related liabilities | 25,331 | 22,340 |
Accrued interest payable | 23,435 | 15,092 |
liability for unsettled share repurchases | 4,463 | 0 |
Accrued Professional Fees, Current | 9,307 | 10,852 |
Sales and marketing incentives | 7,847 | 10,188 |
Sales and other taxes payable | 6,024 | 9,367 |
Accrued Acquisition Costs And Liabilities Current | 5,505 | 9,307 |
Facilities related liabilities | 5,514 | 5,720 |
Other | 8,574 | 11,683 |
Total | $ 203,547 | $ 241,279 |
Deferred Revenue (Detail)
Deferred Revenue (Detail) - USD ($) $ in Thousands | Jun. 30, 2015 | Sep. 30, 2014 |
Current deferred revenue | $ 327,736 | $ 298,225 |
Long-term deferred revenue | 319,895 | 249,879 |
Deferred maintenance revenue | ||
Current deferred revenue | 153,941 | 140,737 |
Long-term deferred revenue | 61,505 | 60,398 |
Unearned revenue | ||
Current deferred revenue | 173,795 | 157,488 |
Long-term deferred revenue | $ 258,390 | $ 189,481 |
Restructuring and Other Charg46
Restructuring and Other Charges, net (Accrual Activity Relating to Restructuring and Other Charges) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | $ 4,726 | |||
Restructuring and other charges, net | $ 7,486 | $ 8,544 | 9,381 | $ 14,100 |
Cash payments | (10,961) | |||
Balance at June 30, 2015 | 3,146 | 3,146 | ||
Personnel | ||||
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | 3,258 | |||
Restructuring and other charges, net | 8,461 | |||
Cash payments | (9,339) | |||
Balance at June 30, 2015 | 2,380 | 2,380 | ||
Facilities | ||||
Restructuring [Roll Forward] | ||||
Balance at September 30, 2014 | 1,468 | |||
Restructuring and other charges, net | 920 | |||
Cash payments | (1,622) | |||
Balance at June 30, 2015 | $ 766 | $ 766 |
Restructuring and Other Charg47
Restructuring and Other Charges, net (By Segment) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | $ 10,808 | $ 8,622 | $ 12,703 | $ 17,178 |
Restructuring and other charges, net | 7,486 | 8,544 | 9,381 | 14,100 |
Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 1,293 | 1,900 | 1,084 | 2,300 |
Restructuring and other charges, net | 1,293 | 1,822 | 1,084 | 2,222 |
Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 6,605 | 1,737 | 6,320 | 1,927 |
Restructuring and other charges, net | 3,283 | 1,737 | 2,998 | 1,927 |
Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 674 | 4,014 | 1,058 | 5,759 |
Restructuring and other charges, net | 674 | 4,014 | 1,058 | 5,759 |
Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 568 | 416 | 2,380 | 547 |
Restructuring and other charges, net | 568 | 416 | 2,380 | 547 |
Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 1,668 | 555 | 1,861 | 6,645 |
Restructuring and other charges, net | 1,668 | 555 | 1,861 | 3,645 |
Personnel | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 6,822 | 7,804 | 10,897 | |
Restructuring and other charges, net | 8,461 | |||
Personnel | Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 659 | 1,811 | 450 | 2,211 |
Personnel | Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 3,253 | 1,115 | 3,140 | 1,305 |
Personnel | Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 674 | 4,014 | 963 | 5,759 |
Personnel | Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 568 | 309 | 2,047 | 440 |
Personnel | Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 1,668 | 555 | 1,861 | 1,182 |
Facilities | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 664 | 740 | 3,203 | |
Restructuring and other charges, net | 920 | |||
Facilities | Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 634 | 11 | 634 | 11 |
Facilities | Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 30 | 622 | 142 | 622 |
Facilities | Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 0 | 0 | 95 | 0 |
Facilities | Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 0 | 107 | 333 | 107 |
Facilities | Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Restructuring and other charges, net | 0 | 0 | 0 | 2,463 |
Other Restructuring [Member] | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Loss Contingency, Loss in Period | 78 | 3,078 | ||
Other Restructuring [Member] | Healthcare | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset Impairment Charges | 0 | 0 | ||
Loss Contingency, Loss in Period | 78 | 78 | ||
Other Restructuring [Member] | Mobile and Consumer | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset Impairment Charges | 3,322 | 3,322 | ||
Loss Contingency, Loss in Period | 0 | 0 | ||
Other Restructuring [Member] | Enterprise | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset Impairment Charges | 0 | 0 | ||
Loss Contingency, Loss in Period | 0 | 0 | ||
Other Restructuring [Member] | Imaging | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset Impairment Charges | 0 | 0 | ||
Loss Contingency, Loss in Period | 0 | 0 | ||
Other Restructuring [Member] | Corporate | ||||
Restructuring Cost and Reserve [Line Items] | ||||
Asset Impairment Charges | $ 0 | $ 0 | ||
Loss Contingency, Loss in Period | $ 0 | $ 3,000 |
Restructuring and Other Charg48
Restructuring and Other Charges, net (Additional Information) (Detail) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2015USD ($) | Jun. 30, 2014USD ($) | Jun. 30, 2015USD ($) | Jun. 30, 2014USD ($) | Sep. 30, 2014USD ($) | |
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring Reserve | $ 3,146 | $ 3,146 | $ 4,726 | ||
Number of personnel eliminated | 200 | ||||
Payments for Restructuring | 10,961 | ||||
Personnel | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and other charges, net | $ 6,822 | $ 7,804 | $ 10,897 | ||
Restructuring Reserve | 2,380 | 2,380 | 3,258 | ||
Payments for Restructuring | 9,339 | ||||
Facilities | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and other charges, net | 664 | 740 | 3,203 | ||
Restructuring Reserve | 766 | 766 | $ 1,468 | ||
Payments for Restructuring | 1,622 | ||||
Mobile and Consumer | Personnel | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and other charges, net | 3,253 | 1,115 | 3,140 | 1,305 | |
Mobile and Consumer | Facilities | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Restructuring and other charges, net | 30 | $ 622 | 142 | $ 622 | |
Mobile and Consumer | Other Restructuring [Member] | |||||
Restructuring Cost and Reserve [Line Items] | |||||
Asset Impairment Charges | $ 3,322 | $ 3,322 |
Debt and Credit Facilities (Add
Debt and Credit Facilities (Additional Information) (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Jun. 30, 2015 | Jun. 30, 2015 | Jun. 30, 2014 | Jun. 01, 2015 | Apr. 29, 2015 | Sep. 30, 2014 | Apr. 29, 2013 | Oct. 24, 2011 | |
Debt Instrument [Line Items] | ||||||||
Long-term debt, face value | $ 2,221,400,000 | $ 2,221,400,000 | $ 2,217,400,000 | |||||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | $ 500,000,000 | $ 500,000,000 | ||||||
Gains (Losses) on Extinguishment of Debt | $ 17,700,000 | $ (17,714,000) | $ 0 | |||||
Amended Credit Agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of Capital Stock of Domestic Subsidiaries Pledged as Collateral | 100.00% | 100.00% | ||||||
Revolving Credit Facility [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt instrument, unamortized discount | $ (900,000) | $ (900,000) | (1,000,000) | |||||
Line of Credit Facility, Maximum Borrowing Capacity | 75,000,000 | 75,000,000 | ||||||
Credit facility, outstanding | 472,924,000 | 472,924,000 | $ 476,399,000 | |||||
Letters of credit, outstanding | $ 5,700,000 | $ 5,700,000 | ||||||
Credit facility, commitment fee percentage for unused capacity | 0.375% | |||||||
Revolving Credit Facility [Member] | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Credit facility, commitment fee percentage for unused capacity | 0.25% | |||||||
Revolving Credit Facility [Member] | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Credit facility, commitment fee percentage for unused capacity | 0.375% | |||||||
Term Loan | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Covenants, Percentage of Net Cash Proceeds from Asset Sales | 100.00% | 100.00% | ||||||
Debt Covenants, Percentage of Net Cash Proceeds from Issuance or Incurrence of Debt | 100.00% | 100.00% | ||||||
Debt Covenants, Percentage of Extraordinary Receipts | 100.00% | 100.00% | ||||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt, face value | $ 263,900,000 | |||||||
Debt instrument, stated interest rate | 1.50% | 1.50% | 1.50% | 0.00% | ||||
Debt instrument, unamortized discount | $ (62,700,000) | $ (62,700,000) | $ (63,000,000) | $ 0 | ||||
Debt Instrument, Interest Rate, Effective Percentage | 5.50% | 5.50% | 0.00% | |||||
Debt Instrument, Maturity Date | 2,035 | |||||||
Proceeds from Convertible Debt | $ 253,500,000 | |||||||
Debt issuance Percentage of Principal Amount | 97.09% | |||||||
Debt Instrument, Unamortized Discount (Premium), Net | $ 7,700,000 | |||||||
Convertible Debt, Noncurrent | 208,600,000 | |||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 55,300,000 | |||||||
Deferred Finance Costs, Noncurrent, Net | 2,200,000 | $ 2,200,000 | ||||||
Debt Instrument, Convertible, Conversion Price | $ 23.26 | |||||||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 100.00% | |||||||
Debt Instrument Conversion Circumstance Number Of Consecutive Trading Days | 5 days | |||||||
Debt Instrument Conversion Circumstance Number Of Consecutive Business Days | 5 days | |||||||
Principal Amount Per Note Used In Conversion Rate | $ 1,000 | $ 1,000 | ||||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | Minimum | ||||||||
Debt Instrument [Line Items] | ||||||||
Ratio of Common Stock Closing Price to Debt Conversion Price, Percentage | 130.00% | 130.00% | ||||||
Debt Instrument Conversion Circumstance Number Of Trading Days | 20 days | |||||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | Maximum | ||||||||
Debt Instrument [Line Items] | ||||||||
Ratio of Common Stock Closing Price to Debt Conversion Price, Percentage | 98.00% | 98.00% | ||||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Long-term debt, face value | $ 433,800,000 | |||||||
Debt instrument, stated interest rate | 2.75% | 2.75% | 2.75% | 2.75% | ||||
Debt instrument, unamortized discount | $ (43,400,000) | $ (43,400,000) | $ (88,800,000) | |||||
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% | 7.43% | |||||
Debt Instrument, Maturity Date | 2,031 | |||||||
Repayments of Convertible Debt | $ 256,200,000 | |||||||
Deferred Finance Costs, Noncurrent, Net | $ 2,600,000 | 2,600,000 | $ 5,500,000 | |||||
5.375% Senior Notes due August 15, 2020 | ||||||||
Debt Instrument [Line Items] | ||||||||
Senior notes, principal amount | $ 1,054,014,000 | $ 1,054,014,000 | $ 1,054,601,000 | |||||
Debt instrument, stated interest rate | 5.375% | 5.375% | 5.375% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% | 5.28% | |||||
Debt Instrument, Maturity Date | 2,020 | |||||||
Unamortized Premium | $ (4,000,000) | $ (4,000,000) | $ (4,600,000) | |||||
Voting Equity Interests [Member] | Amended Credit Agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 65.00% | 65.00% | ||||||
Non-voting Equity Interests [Member] | Amended Credit Agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 100.00% | 100.00% | ||||||
Ending on Last Trading Day of Previous Fiscal Quarter [Member] | Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument Conversion Circumstance Number Of Consecutive Trading Days | 30 days |
Debt and Credit Facilities (Bor
Debt and Credit Facilities (Borrowing Obligations) (Detail) - USD ($) $ in Thousands | 9 Months Ended | |||
Jun. 30, 2015 | Jun. 01, 2015 | Sep. 30, 2014 | Oct. 24, 2011 | |
Debt Instrument [Line Items] | ||||
Total long-term debt | $ 2,118,575 | $ 2,132,226 | ||
Less: current portion | 4,834 | 4,834 | ||
Non-current portion of long-term debt | $ 2,113,741 | $ 2,127,392 | ||
5.375% Senior Notes due August 15, 2020 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 5.375% | 5.375% | ||
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% | ||
Unamortized Premium | $ 4,000 | $ 4,600 | ||
Senior Notes, net of unamortized premium | $ 1,054,014 | $ 1,054,601 | ||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 2.75% | 2.75% | 2.75% | |
Repayments of Convertible Debt | $ 256,200 | |||
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% | ||
Debt instrument, unamortized discount | $ (43,400) | $ (88,800) | ||
Convertible Debentures, net of unamortized discount | $ 390,400 | $ 601,226 | ||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, stated interest rate | 1.50% | 1.50% | 0.00% | |
Debt Instrument, Interest Rate, Effective Percentage | 5.50% | 0.00% | ||
Debt instrument, unamortized discount | $ (62,700) | $ (63,000) | $ 0 | |
Convertible Debentures, net of unamortized discount | 201,237 | 0 | ||
Revolving Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, unamortized discount | (900) | (1,000) | ||
Credit Facility, net of unamortized original issue discount of $0.8 million and $1.0 million respectively. | $ 472,924 | $ 476,399 |
Debt and Credit Facilities (App
Debt and Credit Facilities (Applicable Margin for Borrowings) (Detail) - USD ($) $ in Thousands | 9 Months Ended | ||
Jun. 30, 2015 | Sep. 30, 2014 | ||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 2.75% | ||
Credit Facility, net of unamortized original issue discount of $0.8 million and $1.0 million respectively. | $ 473,800 | ||
Revolving Credit Facility [Member] | |||
Line of Credit Facility [Line Items] | |||
Line of Credit Facility, Maximum Borrowing Capacity | 75,000 | ||
Letters of credit, outstanding | 5,700 | ||
Credit Facility, net of unamortized original issue discount of $0.8 million and $1.0 million respectively. | $ 472,924 | $ 476,399 | |
Credit facility, commitment fee percentage for unused capacity | 0.375% | ||
Revolving Credit Facility [Member] | Minimum | |||
Line of Credit Facility [Line Items] | |||
Credit facility, commitment fee percentage for unused capacity | 0.25% | ||
Revolving Credit Facility [Member] | Maximum | |||
Line of Credit Facility [Line Items] | |||
Credit facility, commitment fee percentage for unused capacity | 0.375% | ||
Base Rate Margin | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 1.75% | ||
Base Rate Margin | Revolving facility due March 2015 | Minimum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | [1] | 0.50% | |
Base Rate Margin | Revolving facility due March 2015 | Maximum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | [1] | 0.75% | |
LIBOR Margin | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | 2.75% | ||
Debt Instrument, Interest Rate, Effective Percentage | 2.94% | ||
LIBOR Margin | Revolving facility due March 2015 | Minimum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | [1] | 1.50% | |
LIBOR Margin | Revolving facility due March 2015 | Maximum | |||
Line of Credit Facility [Line Items] | |||
Applicable margin rate | [1] | 1.75% | |
[1] | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) shares in Millions, $ in Millions | 9 Months Ended | 26 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2015 | Apr. 29, 2015 | Apr. 29, 2013 | |
Stockholders Equity Note [Line Items] | ||||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | $ 500 | $ 500 | ||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | $ 546.5 | $ 546.5 | ||
Stock Repurchased During Period, Shares | 16.5 | 27.9 | ||
Stock Repurchased During Period, Value | $ 242.7 | $ 453.5 |
Net Loss Per Share (Additional
Net Loss Per Share (Additional Information) (Detail) - shares shares in Millions | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive common equivalent shares excluded from computation of diluted net income (loss) per share | 10 | 12.1 | 10.4 | 12.1 |
Stock-Based Compensation (Inclu
Stock-Based Compensation (Included in Consolidated Statements of Operations) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | $ 41,701 | $ 55,382 | $ 119,972 | $ 147,541 |
Cost of product and licensing | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 148 | 238 | 331 | 1,200 |
Cost of professional services and hosting | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 7,833 | 10,528 | 20,185 | 24,346 |
Cost of maintenance and support | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 1,002 | 1,290 | 2,576 | 2,480 |
Research and development | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 9,210 | 12,960 | 26,387 | 33,703 |
Selling and marketing | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | 11,760 | 13,656 | 32,176 | 39,110 |
General and administrative | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock based compensation | $ 11,748 | $ 16,710 | $ 38,317 | $ 46,702 |
Stock-Based Compensation (Addit
Stock-Based Compensation (Additional Information) (Detail) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $ 2.1 | $ 3.1 |
Restricted Stock Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Purchase price for restricted units, vested | $ 0.001 |
Stock-Based Compensation (Summa
Stock-Based Compensation (Summary of Stock Options Activity) (Detail) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Number of Shares | ||
Outstanding at September 30, 2014 | 3,723,342 | |
Exercised | (327,844) | |
Forfeited | (892) | |
Expired | (30,976) | |
Outstanding at June 30, 2015 | 3,363,630 | |
Exercisable | 3,362,385 | 3,749,438 |
Weighted Average Exercise Price | ||
Outstanding at September 30, 2014 | $ 13.46 | |
Exercised | 10.33 | |
Forfeited | 20.04 | |
Expired | 19.30 | |
Outstanding at June 30, 2015 | 13.71 | |
Exercisable | $ 13.71 | $ 13.45 |
Weighted Average Remaining Contractual Term | ||
Outstanding at June 30, 2015 | 1 year 6 months | |
Exercisable | 1 year 6 months | 2 years 6 months |
Aggregate Intrinsic Value | ||
Outstanding at June 30, 2015 | $ 12.9 | |
Exercisable | $ 12.9 | $ 20 |
Stock-Based Compensation (Sum57
Stock-Based Compensation (Summary of Stock Options Activity)(Detail) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Share-based Compensation [Abstract] | ||
Closing market value of common stock | $ 17.51 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $ 2.1 | $ 3.1 |
Stock-Based Compensation (Sum58
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Detail) - Jun. 30, 2015 - USD ($) $ / shares in Units, $ in Millions | Total |
Restricted Stock Awards | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Purchase price for restricted units, vested | $ 0.001 |
Restricted Units, Outstanding [Roll Forward] | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (250,000) |
Outstanding at June 30, 2015 | 500,000 |
Number of Shares Underlying Restricted Units — Contingent Awards | |
Restricted Units, Outstanding [Roll Forward] | |
Outstanding at September 30, 2014 | 5,726,385 |
Granted | 1,771,610 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (1,891,051) |
Forfeited | (646,222) |
Outstanding at June 30, 2015 | 4,960,722 |
Weighted average remaining recognition period of outstanding restricted units | 1 year 5 months |
Unearned stock-based compensation expense of outstanding restricted units | $ 65.2 |
Aggregate intrinsic value of outstanding restricted units(a) | $ 86.9 |
Number of Shares Underlying Restricted Units — Time-Based Awards | |
Restricted Units, Outstanding [Roll Forward] | |
Outstanding at September 30, 2014 | 8,349,107 |
Granted | 7,375,369 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (6,493,760) |
Forfeited | (552,253) |
Outstanding at June 30, 2015 | 8,678,463 |
Weighted average remaining recognition period of outstanding restricted units | 1 year 8 months |
Unearned stock-based compensation expense of outstanding restricted units | $ 94.5 |
Aggregate intrinsic value of outstanding restricted units(a) | $ 152 |
Stock-Based Compensation (Sum59
Stock-Based Compensation (Summary of Activity Relating to Restricted Units)(Detail) | Jun. 30, 2015$ / shares |
Share-based Compensation [Abstract] | |
Closing market value of common stock | $ 17.51 |
Stock-Based Compensation (Sum60
Stock-Based Compensation (Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units Vested) (Detail) - Restricted Stock Units - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average grant-date fair value per share | $ 15.36 | $ 15.39 |
Total intrinsic value of shares vested (in millions) | $ 125.1 | $ 82.7 |
Stock-Based Compensation Stock-
Stock-Based Compensation Stock-Based Compensation (Restricted Stock Awards) (Details) - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Sep. 30, 2014 | |
Restricted Stock [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 21.28 | ||
Outstanding at September 30, 2014 | 750,000 | ||
Weighted average remaining recognition period of outstanding restricted units | 3 months | ||
Unearned stock-based compensation expense of outstanding restricted units | $ 2.2 | ||
Aggregate intrinsic value of outstanding restricted units(a) | $ 8.8 | ||
Weighted Average Grant Date Fair Value, Granted | $ 0 | $ 15.71 | |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value | $ 3.9 | $ 3.9 | |
Restricted Stock Units | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted Average Grant Date Fair Value, Granted | $ 15.36 | $ 15.39 | |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value | $ 125.1 | $ 82.7 | |
Restricted Stock Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 19.01 | ||
Outstanding at June 30, 2015 | 500,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (250,000) | ||
Weighted Average Grant Date Fair Value, Vested | $ 25.80 | ||
Number of Shares Underlying Restricted Units — Contingent Awards | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Outstanding at September 30, 2014 | 5,726,385 | ||
Granted | 1,771,610 | ||
Forfeited | 646,222 | ||
Outstanding at June 30, 2015 | 4,960,722 | ||
Weighted average remaining recognition period of outstanding restricted units | 1 year 5 months | ||
Unearned stock-based compensation expense of outstanding restricted units | $ 65.2 | ||
Aggregate intrinsic value of outstanding restricted units(a) | $ 86.9 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | (1,891,051) |
Income Taxes (Components of Ben
Income Taxes (Components of Benefit from Income Taxes) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Income Tax Disclosure [Abstract] | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $ 2,100 | |||
Domestic Tax Expense (Benefit) | 1,728 | $ 4,710 | $ 11,414 | $ 8,505 |
Foreign | 4,805 | 2,249 | 11,992 | 7,826 |
Provision for income taxes | $ 6,533 | $ 6,959 | $ 23,406 | $ 16,331 |
Effective tax rate | (19.90%) | (14.70%) | (29.00%) | (12.30%) |
Income Taxes (Additional Inform
Income Taxes (Additional Information) (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Sep. 30, 2014 | |
Business Acquisition [Line Items] | |||||
Income taxes associated with uncertain tax position | $ 21,900,000 | $ 21,900,000 | $ 21,200,000 | ||
U.S. federal statutory income tax rate | 35.00% | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $ 2,100,000 | ||||
Effective tax rate | (19.90%) | (14.70%) | (29.00%) | (12.30%) | |
Provision for income taxes | $ 6,533,000 | $ 6,959,000 | $ 23,406,000 | $ 16,331,000 | |
Unrecognized Tax Benefits Expected To Be Resolved With In A Year | $ 0 | $ 0 |
Income Taxes (Loss) income befo
Income Taxes (Loss) income before income taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Income Tax Disclosure [Abstract] | ||||
Income (Loss) from Continuing Operations before Income Taxes, Domestic | $ (65,222) | $ (51,233) | $ (166,157) | $ (172,860) |
Income (Loss) from Continuing Operations before Income Taxes, Foreign | 32,365 | 3,945 | 85,580 | 40,304 |
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest | $ (32,857) | $ (47,288) | $ (80,577) | $ (132,556) |
Income Taxes Deferred Tax Expen
Income Taxes Deferred Tax Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Income Taxes [Line Items] | ||||
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | $ 2,100 | |||
Provision for income taxes | 6,533 | $ 6,959 | $ 23,406 | $ 16,331 |
Goodwill [Member] | ||||
Income Taxes [Line Items] | ||||
Provision for income taxes | $ 3,500 | $ 10,600 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | 9 Months Ended |
Jun. 30, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
Indemnification term for former officers and directors | 6 years |
Segment and Geographic Inform67
Segment and Geographic Information and Significant Customers (Additional Information) (Detail) | 9 Months Ended |
Jun. 30, 2015Segment | |
Segment Reporting [Abstract] | |
Number of reportable business segments | 4 |
Segment and Geographic Inform68
Segment and Geographic Information and Significant Customers (Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Segment Reporting Information [Line Items] | ||||
Revenue | $ 488,656 | $ 486,814 | $ 1,465,749 | $ 1,466,832 |
Revenues | 477,939 | 475,504 | 1,427,017 | 1,421,137 |
Segment profit | 155,462 | 139,826 | 445,113 | 422,650 |
Corporate expenses and other, net | (31,226) | (25,292) | (102,344) | (86,624) |
Acquisition-related revenues and cost of revenues adjustment | (10,198) | (10,450) | (36,576) | (42,319) |
Stock-based compensation | (41,701) | (55,382) | (119,972) | (147,541) |
Amortization of intangible assets | (42,147) | (42,293) | (125,064) | (126,872) |
Acquisition-related costs, net | (2,423) | (9,110) | (13,702) | (18,710) |
Restructuring and other charges, net | (10,808) | (8,622) | (12,703) | (17,178) |
Costs associated with IP collaboration agreements | (2,625) | (4,937) | (8,501) | (14,811) |
Other expense, net | (47,191) | (31,028) | (106,828) | (101,151) |
Loss before income taxes | (32,857) | (47,288) | (80,577) | (132,556) |
Healthcare | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 236,855 | 240,099 | 696,439 | 704,382 |
Segment profit | 81,846 | 84,916 | 239,966 | 254,853 |
Restructuring and other charges, net | (1,293) | (1,900) | (1,084) | (2,300) |
Mobile and Consumer | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 108,577 | 106,978 | 332,614 | 326,690 |
Segment profit | 26,959 | 19,677 | 72,468 | 48,507 |
Restructuring and other charges, net | (6,605) | (1,737) | (6,320) | (1,927) |
Enterprise | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 86,966 | 87,286 | 260,911 | 269,020 |
Segment profit | 24,895 | 18,346 | 68,909 | 59,019 |
Restructuring and other charges, net | (674) | (4,014) | (1,058) | (5,759) |
Imaging | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 56,258 | 52,451 | 175,785 | 166,740 |
Segment profit | 21,762 | 16,887 | 63,770 | 60,271 |
Restructuring and other charges, net | (568) | (416) | (2,380) | (547) |
Acquisition-related revenues | ||||
Segment Reporting Information [Line Items] | ||||
Revenues | $ (10,717) | $ (11,310) | $ (38,732) | $ (45,695) |
Segment and Geographic Inform69
Segment and Geographic Information and Significant Customers (Classification of Revenue by Major Geographic Areas) (Detail) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $ 488,656 | $ 486,814 | $ 1,465,749 | $ 1,466,832 |
Total revenues | 477,939 | 475,504 | 1,427,017 | 1,421,137 |
UNITED STATES | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | 352,033 | 350,363 | 1,052,155 | 1,040,135 |
International [Member] | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Revenue | $ 125,906 | $ 125,141 | $ 374,862 | $ 381,002 |